Investment thesis
Life science investor making venture, growth, credit and principal investments across the healthcare sector.
Sesamers tracks 4 portfolio companies across 5 rounds, 4 of them as lead investor. Its most recent tracked deal: OMass Therapeutics, Oct 2026.
Portfolio
Past investments
| Company | Round | Role | Date | Round size |
|---|---|---|---|---|
| OMass Therapeutics Oxford, United Kingdom | Series C | Lead | Oct 2026 | €276.1M |
| AnaCardio Stockholm, Sweden Read the announcement → | Series B | Lead | Sep 2026 | €62.5M |
| Breye Therapeutics Hørsholm, Denmark Read the announcement → | Series A | Lead | Sep 2026 | €67.5M |
| Reduced Copenhagen, Denmark | Series A | Participant | Feb 2026 | €4M |
| Reduced Copenhagen, Denmark | Seed | Lead | Apr 2024 | €6M |